BBI
Manufacturing · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Pen-y-fan Industrial Estate unit 2 Pkwy,...Phone Number
+441495363000Website
www.bbisolutions.comRevenue
$235.5 MillionIndustry
ZI Rank: 8
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
6
8
14
10
8
About BBI
BBI Solutions is a biotechnology company and supplier of products and services to the global diagnostics and life sciences industries. Their portfolio of products includes gold reagents, antibodies, antigens, enzymes, serum and plasma, cell culture reagents as well as offering antibody development services, lateral flow assay development and manufacture and the Novarum smartphone diagnostic platform. The company is based in the United Kingdom.Explore more
BBI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BBI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BBI has new funding data
BBI, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when BBI launches new products
Website visits: Recent activity has been detected on your website
Check out if BBI is spiking on competitors!
Check if BBI has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BBI
Earning: See what the market has to say on BBI recently announced quarterly report
Click to see if BBI had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to BBI
Compare insights from companies similar to BBI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BBI is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
BBI is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about BBI.
BBI Tech Stack
A closer look at the technologies used by BBI
See more technologies
Most Recent Scoops
Open Position
Left Company
Management Move
Brian Long, Director, Business Services, has left the organization and now serves as Director, Business Services at Optimas OE Solutions LLC.
Event
Events, Business Intelligence, Engineering, Analytics & Insights, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Chemical Engineering, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events, Business Intelligence, Engineering, Analytics & Insights, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Chemical Engineering, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Project
Spending/Investment
BBI News & Media
BBI Solutions appoints Alexander A. Socarrás as Chief Executive Officer
CRUMLIN, Wales, Jan. 8, 2025 /PRNewswire/ -- BBI Solutions Limited ("BBI"), global leader in the development and manufacture of IVD reagents, announces a CEO succession. After 7 years as CEO, Mario Gualano will be leaving BBI on 31 March 2025. With more than 30 years of experience in the...IBEX Shareholders Approve Sale of the Company
MONTRÉAL, Québec, April 03, 2024 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) is pleased to announce that at an annual and special meeting held today, IBEX shareholders approved the previously-announced proposed amalgamation (the “Amalgamation”) of IBEX and 15720273 Canada Inc., a newly-incorporated wholly-owned subsidiary of BBI Solutions OEM Limited (“BBI”), whereby BBI will acquire all of the issued and outstanding shares of IBEX at a price of $1.45Gold Nanoparticles Market to Witness Significant Revenue Growth During the Forecast Period, 2020-2027 : Goldsol, Cytodiagnostics, BBI Solutions, Etc
New York, NY -- (SBWIRE) -- 12/08/2020 -- Reports and Data’s newest report titled ‘Global Gold Nanoparticles Market Forecast to 2027’ is inclusive of an all-encompassing study of the global Gold Nanoparticles market. Read the full press release at http://www.sbwire.com/press-releases/gold-nanoparticles-market-to-witness-significant-revenue-growth-during-the-forecast-period-2020-2027-goldsol-cytodiagnostics-bbi-solutions-etc-1319596.htmAvacta Appoints COVID-19 Rapid Antigen Test Manufacturing Partner
CAMBRIDGE, England & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has appointed BBI Solutions, part of BBI Group (“BBI”), to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva. BBI Solutions is a leading global developer and manufacturer of raw materials and finished test products for the in-vitro diagnostics market, with manufacturing sites
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BBI
Sign Up For FreeTo access detailed company insights
BBI Solutions is a biotechnology company and supplier of products and services to the global diagnostics and life sciences industries. Their portfolio of products includes gold reagents, antibodies, antigens, enzymes, serum and plasma, cell culture reagents as well as offering antibody development services, lateral flow assay development and manufa... Read More
